Biotechnology company
Appears in 1 story
Phase 1 trial of MNA-001 (oral TREM2 agonist) underway in healthy adult volunteers; topline safety and biomarker data expected late summer 2026
Many people carry amyloid plaques in their brains and never lose their memory. Others with similar plaques slide into dementia. A June 2026 study in Nature Medicine says the difference comes down to how the brain's immune cells respond when amyloid meets tau protein.
Updated Jul 27
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
